Biosimilars have the potential to reduce health care costs and expand patient access, but economic and policy barriers affect ...

Tufts Medicine recorded an operating loss of $28.9 million (-4.1% operating margin) in the first quarter of 2025.

The university will change its approval process for team trainings, among other recommended remedies, after the group workout ...